Highlights
NASDAQ: ONCE       Spark Therap Cmn
Last Price Today's Change   Day's Range   Trading Volume
56.84   +2.00 (3.65%)  54.676 - 56.94  134,329

Overview

Avg Volume (4 weeks):0
4 Weeks Range:48.26 - 56.94
52 Weeks Range:31.14 - 65.99
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a Phase I/II clinical trial and a product candidate for hemophilia A, which is in a Phase I/II clinical trial. Its product investigational candidate, voretigene neparvovec, is intended to treat a genetic blinding condition or inherited retinal disease (IRD). The programs targeting hematologic disorders include SPK-FIX, for which the lead product candidate, SPK-9001, is in a Phase I/II clinical trial for the treatment of hemophilia B, as well as SPK-FVIII for the treatment of hemophilia A. In its SPK-FVIII program for the treatment of hemophilia A, the Company has initiated a dose-escalating Phase I/II clinical trial for its lead product candidate, SPK-8011.

  Be the first to like this.
 


 

4418  2693  561  651 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BAC 24.226+0.596 
 JNUG 4.32-0.93 
 BABY 40.95+0.35 
 AKS 6.47-0.65 
 NUGT 8.005-1.355 
 SPY 238.73+1.56 
 GDX 22.075-1.125 
 ABX 17.02-2.02 
 FCX 12.895+0.665 
 XLF 23.95+0.27 
Partners & Brokers